数据出境的新合规要求
2023年2月24日,国家互联网信息办公室公布《个人信息出境标准合同办法》(以下简称《办法》)并于 2023 年 6 月 1 日生效。《办法》明确了个人信息出境标准合同(以下简称"标准合同")的订立、备案等要求,为《个人信息保护法》视域下的个人信息跨境方式之一的"标准合同"提供了落地蓝本与中国方案。新合规要求将对跨行业的跨国公司产生重大影响。
医疗保健、制药和生命科学行业与健康数据和医疗数据等敏感的个人数据有着密切的联系。 后疫情时代,互联网医疗、医疗器械数字化、医药制造等方兴未艾。 鉴于健康和医疗数据的高度敏感性,跨国公司在收集和处理医疗和健康数据方面的合规性面临越来越大的挑战,特别是如何管理与中国相关的跨境数据传输。 《数据跨境传输标准合同条款办法》(2 月 24 日发布,6 月 1 日生效)将对跨国公司产生重大影响,尤其是在信息数据、能源、制药、医疗器械和生命科学领域。
中国美国商会法律工作组和医疗工作组将共同举办此活动,我们邀请Reedsmith律所的专家分享专业见解,主要讨论中国SCC与跨国公司通常采用的国际SCC比较及协同效应,以及探讨采取哪些行动来确保企业数据出境的合规性和风险管理。我们还将提供问答环节,由专业法律人士为企业解惑答疑。
活动详情:
- 活动形式:线上+线下
- 线下地点:北京市朝阳区建国门外大街1号国贸写字楼1座1101室,礼德律师事务所
- 时间和日期:3 月 21 日,下午 3:00 - 4:30
- 联系人:Ada Yang,ayang@amchamchina.org;Edward Wang, xwang@amchamchina.org
注意:
- 活动需要线上注册,我们不接受现场注册。 请提前购票。 注册将于 3 月 20 日下午 5:00 截止。
- 活动开始前48小时票不可退还。
- 请务必使用您公司的电子邮件地址进行注册。
Cyberspace Administration of China issued the Measures on Standard Contracts for Personal Information Export ("Standard Contracts Measures") on February 24, 2023, which will be effective on June 1, 2023. So far, the legal basis for the three approaches for personal information processors to provide personal information outside the People's Republic of China stipulated in Article 38 of the Personal Information Protection Law has been completed. Compared with "security assessment" and "personal information protection certification", concluding a "standard contract" is undoubtedly the most direct and convenient way among the three approaches. It will affect a lot of Foreign companies in China.
Healthcare, pharma and life sciences industries have close connections with sensitive personal data such as health data and medical data. In the post-COVID era, Internet healthcare and digitalization of medical devices and pharma manufacturing have been booming. Given the high sensitivity of health and medical data, MNCs are facing increasingly significant challenges in achieving compliance in collecting and processing medical and health data, particularly how to manage China-related cross-border data transfers. The Measures on the Standard Contract Clauses for Cross-Border Data Transfer (issued on 24 February and effective on 1 June) will have significant implications for MNCs especially in the healthcare, pharma, medical devices and life sciences sectors.
The legal committee and Healthcare committee of AmCham China will jointly hold this event and invite specialist from ReedSmith to share their insights. We will discuss the comparison between China's SCCs and international SCCs usually adopted by MNCs, and explore what actions can be taken to ensure compliance and risk management. There will be Q&A session at the end. The member companies can share their challenges and our guest speaker will help to provide the suggestions.
Event Details:
- Event format: Hybrid
- Offline venue: 1101 China World Office 1, 1 Jianguomenwai Avenue, Beijing
- Time & Date: March 21, 3:00pm - 4:30pm
- Contact: Ada Yang, ayang@amchamchina.org; Edward Wang, xwang@amchamchina.org
Notes:
- Registration is required and due to limited capacity, we cannot accept registrations at the door. Please purchase your tickets in advance. Registration will close at 5:00 PM, March 20.
- Tickets are non-refundable within 48 hours before the start of event.
- Please make sure to register with your company email address.